Recruiting Advanced Solid Tumors Studies in Sydney
A Study of D3S 001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
This is a first-in-human (FIH), multicenter, open-label, dose-escalation, and dose-expansion Phase 1/2 clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and prel...
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors....
About Advanced Solid Tumors Clinical Trials in Sydney
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 2 advanced solid tumors clinical trials recruiting participants in Sydney, . These studies are seeking a combined 587 participants. Research is being sponsored by D3 Bio (Wuxi) Co., Ltd, Shasqi, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Sydney — FAQ
Are there advanced solid tumors clinical trials in Sydney?
Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Sydney, . Browse the studies on this page to find one that fits.
How do I join a clinical trial in Sydney?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sydney research site will contact you about next steps.
Are clinical trials in Sydney free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sydney studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 2 active trials in Sydney are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov